Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, and Dr. Emma Billington. Recommendations from Osteoporosis Canada Rapid Response Team. The Canadian Centre on Substance Use and […]

Osteoporosis can have a significant impact on our physical and emotional well-being including how broken bones and the diagnosis of osteoporosis can affect our sexuality and intimacy. Sexuality can be […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada • Dr. Rick Adachi, Rheumatologist, McMaster University • Dr. Robert Josse, Endocrinologist, University of Toronto • Dr. […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

Managing Pain You may or may not experience pain with a diagnosis of osteoporosis. There are several reasons why an individual with osteoporosis might experience pain: As described above, fractures […]

After The Spine Fracture Heals Sometimes back pain continues. The various stages of healing will take place over several months but the recovery of function and muscle strength can also be a […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

Hip Fractures Hip fractures from osteoporosis are usually the result of a fall and most commonly occur in people in their late 70s or 80s. A broken hip will require hospitalization and […]